Learn More
Invitrogen™ CD30L (TNFSF8) Mouse ELISA Kit
Sandwich ELISA Kit
5440.00 SEK - 42040.00 SEK
Specifications
Accession Number | P32972 |
---|---|
Assay Sensitivity | 0.6 pg/mL |
Assay | Solid-phase sandwich ELISA |
Conjugate | Biotin |
Product Type | ELISA Kit |
Product Code | Brand | Quantity | Price | Quantity & Availability | |||||
---|---|---|---|---|---|---|---|---|---|
Product Code | Brand | Quantity | Price | Quantity & Availability | |||||
18507934
|
Invitrogen™
EMTNFSF8X10 |
10 x 96 Tests |
42040.00 SEK
Pack of 10 |
Estimated Shipment: 14-06-2024 Log in to see stock. |
Please sign in to purchase this item. Need a web account? Register with us today! | ||||
15415353
|
Invitrogen™
EMTNFSF8 |
96 Tests |
5440.00 SEK
1 set |
Estimated Shipment: 29-05-2024
Log in to see stock. |
|||||
Description
The Mouse CD30L (TNFSF8) ELISA quantitates Ms CD30L in mouse serum, plasma, or cell culture medium. The assay will exclusively recognize both natural and recombinant Ms CD30L. Principle of the method The Mouse CD30L solid-phase sandwich ELISA (enzyme-linked immunosorbent assay) is designed to measure the amount of the target bound between a matched antibody pair. A target-specific antibody has been pre-coated in the wells of the supplied microplate. Samples, standards, or controls are then added into these wells and bind to the immobilized (capture) antibody. The sandwich is formed by the addition of the second (detector) antibody, a substrate solution is added that reacts with the enzyme-antibody-target complex to produce measurable signal. The intensity of this signal is directly proportional to the concentration of target present in the original specimen. Rigorous validation Each manufactured lot of this ELISA kit is quality tested for criteria such as sensitivity, specificity, precision, and lot-to-lot consistency. See manual for more information on validation.
The ligand for CD30 is CD30L (CD153). The binding of CD30 to CD30L mediates pleiotropic effects including cell proliferation, activation, differentiation, and apoptotic cell death. CD30 has a critical role in the pathophysiology of Hodgkin's disease and other CD30+ lymphomas. CD30 acts as a costimulatory molecule in thymic negative selection. In addition to its expression on Hodgkin's and Reed-Sternberg cells, CD30 is also found in some non-Hodgkin's lymphomas (including Burkitt's lymphomas), virus-infected T and B cells, and on normal T and B cells after activation. In T cells, CD30 expression is present on a subset of T cells that produce Th2-type cytokines and on CD4+/CD8+ thymocytes that coexpress CD45RO and the IL4 receptor.Specifications
P32972 | |
Solid-phase sandwich ELISA | |
ELISA Kit | |
96 assays | |
ELISA, Protein Assays, Protein Biology, Cancer Biology, Immunology, Neuroscience, Neurobiology, Protein Detection, Protein Analysis | |
21949 | |
<12% | |
HRP | |
Immunology | |
CD153, CD30LG, Cd30l | |
1 hr. 20 min. |
0.6 pg/mL | |
Biotin | |
CD Proteins | |
Mouse | |
Colorimetric Microplate Reader | |
CD153,CD30LG,Cd30l,Tnlg3a | |
<10% | |
RUO | |
2°C to 8°C | |
Mouse | |
4 hr. 45 min. |